# US 11,998,343 B2 · Annotation of slow electrophysiological (EP) cardiac paths related to ventricular tachycardia (VT)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,998,343 B2
- Document ID: US11998343B2
- Status: Granted
- Kind: B2
- Application number: 17/234,032
- Filed: 2021-04-19
- Published: 2022-10-20
- Granted: 2024-06-04
- Earliest claimed: 2021-04-19
- Assignees: Biosense Webster (Israel) Ltd.
- Applicants: Biosense Webster (Israel) Ltd.
- Inventors: Tal Haim Bar-on; Meir Bar-Tal; Gal Hayam; Einat Shapira
- Web page: https://patentgrep.com/patent/US11998343B2

## CPC

- A61B 5/363: Detecting tachycardia or bradycardia
- A61B 5/6852: {Catheters}
- A61B 5/287: Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
- A61B 5/308: for electrocardiography [ECG]
- A61B 5/333: Recording apparatus specially adapted therefor
- A61B 5/343: Potential distribution indication
- A61B 5/367: Electrophysiological study [EPS], e.g. electrical activation mapping or electro-anatomical mapping
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/7267: {involving training the classification device}
- A61B 5/743: {Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots}
- A61N 1/3625: {External stimulators}
- A61B 5/061: {Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body (A61B1/00158 takes precedence)}
- A61B 2562/04: Arrangements of multiple sensors of the same type
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A method for evaluation of electrical propagation in the heart includes receiving a pacing signal applied to a heart of a patient, the pacing signal including a sequence of normal and shorter, abnormal, pacing stimuli. A responsive cardiac signal is received, that is sensed by electrodes at a location in the heart and on the body surface of the patient. A model response is found and annotated from evoked potentials caused by the normal pacing stimuli. A correlation is made between the model response along the different signal sections to find and calculate a normal and decremental time delays between the pacing stimuli and respectively resulting evoked potentials at a tissue location. A time difference is calculated, between the normal time delay and the decremental time delay. An EP map of at least a portion of the heart is presented to a user, with a graphical indication of the time difference presented at the tissue location.

## Claims

### Claim 1

A method for evaluation of electrical propagation in a heart of a patient, the method comprising:
applying a pacing signal to the heart of the patient by electrodes on a catheter, the pacing signal comprising (i) a sequence of normal pacing stimuli at sinus-rate intervals, and (ii) one or more abnormal pacing stimuli at abnormal intervals that are shorter than the sinus-rate intervals;
receiving, in response to the applied pacing signal, a cardiac signal that is sensed by the catheter electrodes at a location in the heart;
identifying and annotating a model response from evoked potentials in the cardiac signal caused by the normal pacing stimuli, the annotated model response being one of the evoked potentials having a high correlation of stimulated points of cardiac activity to the other evoked potentials in the cardiac signal;
determining, for each interval between paces of the paced signal, scorings of correlations with the model response along each of the respective intervals between paces of the paced signal;
annotating a first set of the evoked potentials in the cardiac signal caused by the normal pacing stimuli and a second set of the evoked potentials in the cardiac signal caused by the one or more abnormal pacing stimuli, the first and second sets of evoked potentials being other than the evoked potential of the model and being annotated based upon the scorings of correlations, each annotation in each interval of the paced signal being identified as an index that received the highest scoring with the model response for that interval;
determining a first time delay between the normal pacing stimuli and the resulting evoked potentials in the cardiac signal and a second time delay between the abnormal pacing stimuli and the resulting evoked potentials in the cardiac signal;
determining a decremental time delay, the decremental time delay being a time difference between the first time delay and the second time delay; and
presenting an EP map of at least a portion of the heart to a user, with a graphical indication of the decremental time delay presented at the one or more locations in the heart.

### Claim 2 (depends on 1)

The method according to claim 1, wherein determining the first time delay and the second time delay comprises annotating the cardiac signal at the determined first and second delays.

### Claim 3 (depends on 1)

The method according to claim 1, and comprising receiving a respective electrocardiogram (ECG) signal from electrodes external to the patient and, using the ECG signal, estimating whether a stable contraction occurred in response to a predefined number of normal pacing stimuli and to a first abnormal pacing stimuli, and discarding a portion of the cardiac signal for which the respective ECG does not indicate stable contraction.

### Claim 4 (depends on 3)

The method according to claim 3, wherein estimating the stable contraction comprises estimating a repeatability of the evoked potentials in the cardiac signal.

### Claim 5 (depends on 3)

The method according to claim 3, wherein estimating the stable contraction comprises smoothing the cardiac signal and detecting the evoked potentials in the smoothed bipolar signal.

### Claim 6 (depends on 1)

The method according to claim 1, wherein presenting the EP map comprises adjusting a scale of a GUI to define a minimal positive value of the time difference to be displayed on the EP map.

### Claim 7 (depends on 1)

The method according to claim 1, wherein presenting the EP map comprises overlaying on the EP map an artificial icon, which is graphically coded to indicate a value of the time difference.

### Claim 8 (depends on 1)

The method according to claim 1, wherein presenting the EP map further comprises indicating to the user an occurrence of aberrant ventricular activity.

### Claim 9 (depends on 8)

The method according to claim 8, wherein indicating the occurrence of aberrant ventricular activity comprises using at least one of a color and surface morphology on the EP map.

### Claim 10 (depends on 1)

The method according to claim 1, wherein receiving the cardiac signal comprises receiving unipolar and bipolar electrograms from the electrodes.

### Claim 11 (depends on 1)

The method according to claim 1, wherein determining the highest scoring correlation comprises training a machine learning model to estimate a highest scoring correlation based on a prespecified metric.

### Claim 12

A system for evaluation of electrical propagation in a heart of a patient, the system comprising:
a catheter having a plurality of electrodes configured to apply a pacing signal to the heart of the patient;
one or more processors; and
a non-transitory computer readable medium storing a plurality of instructions, which when executed, cause the one or more processors to:
apply a pacing signal to the heart of the patient by the electrodes on the catheter, the pacing signal comprising (i) a sequence of normal pacing stimuli at sinus-rate intervals, and (ii) one or more abnormal pacing stimuli at abnormal intervals that are shorter than the sinus-rate intervals;
receive from the catheter electrodes, in response to the applied pacing signal, a cardiac signal that is sensed by the catheter electrodes at a location in the heart; and
identify and annotate a model response from evoked potentials in the cardiac signal caused by the normal pacing stimuli, the annotated model response being one of the evoked potentials having a high correlation based upon a prespecified metric to the other evoked potentials in the cardiac signal;
determine, for each interval between paces of the paced signal, scorings of correlations with the model response along each of the respective intervals between paces of the paced signal;
annotate a first set of the evoked potentials in the cardiac signal caused by the normal pacing stimuli and a second set of the evoked potentials in the cardiac signal caused by the one or more abnormal pacing stimuli, the first and second sets of evoked potentials being other than the evoked potential of the model and being annotated based upon the scorings of correlations, each annotation in each interval of the paced signal being identified as an index that received the highest scoring with the model response for that interval;
determine a first time delay between the normal pacing stimuli and the resulting evoked potentials in the cardiac signal and a second time delay between the abnormal pacing stimuli and the resulting evoked potentials in the cardiac signal;
determine a decremental time delay, the decremental time delay being a time difference between the first time delay and the second time delay; and
cause an EP map of at least a portion of the heart to be presented on a graphical user interface (GUI) electronically coupled to the one or more processors, with a graphical indication of the decremental time delay presented at the one or more locations in the heart.

### Claim 13 (depends on 12)

The system according to claim 12, wherein the plurality of instructions further cause the one or more processors to determine the first time delay and the second time delay comprises annotating the cardiac signal at the determined first and second delays.

### Claim 14 (depends on 12)

The system according to claim 12, wherein the plurality of instructions further cause the one or more processors to receive a respective electrocardiogram (ECG) signal from electrodes external to the patient and wherein the processor is configured to estimate, using the ECG signal, whether a stable contraction occurred in response to a predefined number of normal pacing stimuli and to the first abnormal pacing stimuli, and to discard a portion of the cardiac signal for which the respective ECG does not indicate stable contraction.

### Claim 15 (depends on 14)

The system according to claim 14, wherein the plurality of instructions further cause the one or more processors to estimate the stable contraction by estimating a repeatability of the evoked potentials in the cardiac signal.

### Claim 16 (depends on 14)

The system according to claim 14, wherein the plurality of instructions further cause the one or more processors to estimate the stable contraction by smoothing the cardiac signal and detecting the evoked potentials in the smoothed bipolar signal.

### Claim 17 (depends on 12)

The system according to claim 12, wherein the plurality of instructions further cause the one or more processors to present the EP map by adjusting a scale of the GUI to define a minimal positive value of the time difference to be displayed on the EP map.

### Claim 18 (depends on 12)

The system according to claim 12, the plurality of instructions further cause the one or more processors to cause the EP map to be presented by overlaying on the EP map an artificial icon, which is graphically coded to indicate a value of the time difference.

### Claim 19 (depends on 12)

The system according to claim 12, wherein the plurality of instructions further cause the one or more processors to present the EP map by indicating to the user an occurrence of aberrant ventricular activity.

### Claim 20 (depends on 19)

The system according to claim 19, wherein the plurality of instructions further cause the one or more processors to indicate the occurrence of aberrant ventricular activity by using at least one of a color and surface morphology on the EP map.

### Claim 21 (depends on 12)

The system according to claim 12, wherein the plurality of instructions further cause the one or more processors to receive the cardiac signal by receiving unipolar and bipolar electrograms from the electrodes.

### Claim 22 (depends on 12)

The system according to claim 12, further comprising a machine learning model, wherein the plurality of instructions further cause the one or more processors to determine the highest scoring correlation by training the machine learning model to estimate a highest scoring correlation based on a prespecified metric.